https://www.selleckchem.com/pr....oducts/kd025-(slx-21
com/liushaomin/MitosisDetection.Non-small cell lung cancer (NSCLC) caused by the mutation of epidermal growth factor receptor (EGFR) is a major cause of death worldwide. EGFR Tyrosine kinase inhibitors (TKIs) have been developed against the EGFR. These TKIs produce promising results at initial stage of therapy, but the efficacy becomes limited due to the emergence of drug resistance in most cases after about an year, due to a secondary point mutation. In this work, we investigated the drug resistance mechanism due to the EGFR m